Biography
Professional Summary
Education & Certifications
- Medical Education: University of Western Ontario Schulich School of Medicine (2009) Canada
- Clinical Fellowship, Stanford University, School of Medicine, MS/Neuroimmunology (2016)
- Research Fellowship, University College London, London, UK, MS Advanced Neuroimaging (2015)
-
- Neurology Residency, University of British Columbia, Vancouver, Canada (2014)
- Doctor of Medicine (MD), University of Western Ontario, London, Canada (2009)
- Bachelor of Science (BSc), University of Western Ontario, London, Canada (2005)
Honors & Awards
- Henry J. Kaiser Family Foundation Award for Excellence in Clinical Teaching, Stanford University, School of Medicine (2019)
- Lysia S. Forno Award for Outstanding Contributions to Resident Teaching, Stanford University, Department of Neurology & Neurological Sciences (2023)
- MS Clinical Fellowship Award, Canadian Network of Multiple Sclerosis Clinics (2014)
-
- Medical Student Neurology Clinical Clerkship Faculty Teaching Award, Stanford University, Department of Neurology & Neurological Sciences (2017, 2018, 2020, 2021, 2022)
- Science Breakthrough of the Year, runner-up, American Association for the Advancement of Science (2022)
- Top 10 Master Neurology Outpatient Educators, Stanford Neurology Residents (2022)
Memberships
- Fellow, Royal College of Physicians and Surgeons of Canada (2014 - Present)
- Member, American Academy of Neurology (2008 - Present)
- Member, National Consortium of MS Clinics (2016 - Present)
-
Administrative Appointments
- Co-Lead Quarter 6, Practice of Medicine II, Stanford University, School of Medicine (2020 - Present)
- Director, MS/Clinical Neuroimmunology Fellowship, Department of Neurology & Neurological Sciences, Stanford University (2016 - Present)
- Director, Neurology Grand Rounds, Department of Neurology & Neurological Sciences, Stanford University (2018 - 2023)
-
- Education Chief, Division of Clinical Neuroimmunology, Department of Neurology & Neurological Sciences, Stanford University (2016 - Present)
- Faculty Coach, Neurology Resident Communication Coaching Program, Department of Neurology & Neurological Sciences, Stanford University (2019 - Present)
- Service Representative, Medical Executive Committee (MEC), Stanford Health Care (SHC) (2024 - Present)
Publications
-
Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry
Sadovnick, A. D., Yee, I. M., Attwell-Pope, K., Keyes, G., Kipp, L., & Traboulsee, A. L. (2017). Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 44(3), 246–54. -
Autoimmune Hepatitis During Treatment of Multiple Sclerosis with Alemtuzumab
Carlson, A., Bozinov, N., Kipp, L., Dunn, J., & Lock, C. (2018). Autoimmune Hepatitis During Treatment of Multiple Sclerosis with Alemtuzumab. NEUROLOGY, 90. -
Coexistence of Neuromyelitis Optica and Amyotrophic Lateral Sclerosis: A Case Report
Li, A., McGranahan, T., Su, E., Kipp, L., & Gold, C. A. (2019). Coexistence of Neuromyelitis Optica and Amyotrophic Lateral Sclerosis: A Case Report. NEUROHOSPITALIST, 9(1), 37–40. -
-
Immunomodulatory receptors are differentially expressed in B and T cell subsets relevant to autoimmune disease.
Murphy, K. A., Bhamidiphati, K., Rubin, S. J., Kipp, L., Robinson, W. H., & Lanz, T. V. (2019). Immunomodulatory receptors are differentially expressed in B and T cell subsets relevant to autoimmune disease. Clinical Immunology (Orlando, Fla.), 108276. -
Reduced neurite density in the brain and cervical spinal cord in relapsing-remitting multiple sclerosis: A NODDI study.
Collorone, S., Cawley, N., Grussu, F., Prados, F., Tona, F., Calvi, A., … Ciccarelli, O. (2019). Reduced neurite density in the brain and cervical spinal cord in relapsing-remitting multiple sclerosis: A NODDI study. Multiple Sclerosis (Houndmills, Basingstoke, England), 1352458519885107. -
A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism.
Tomczak, A., Su, E., Tugizova, M., Carlson, A. M., Kipp, L. B., Feng, H., & Han, M. H. (2019). A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism. Multiple Sclerosis and Related Disorders, 39, 101900. -
Association of GAD-65 Antibodies with Autonomic Dysfunction in non-Type I diabetic patients
Bozinov, N., Kipp, L., Nguyen, L., & Jaradeh, S. (2020). Association of GAD-65 Antibodies with Autonomic Dysfunction in non-Type I diabetic patients. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Novel microscopic foveal pit pathology in multiple sclerosis revealed with adaptive optics ophthalmoscopy
Hargrave, A., Sredar, N., Razeen, M. M., Khushzad, F., Yarp, J., Leishangthem, L., … Moss, H. (2020). Novel microscopic foveal pit pathology in multiple sclerosis revealed with adaptive optics ophthalmoscopy. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. -
Comparison of visual function and retinal structure between phases of multiple sclerosis
Yarp, J., Khushzad, F., Leishangthem, L., Mahesh, V., Tomczak, A., Han, M., … Moss, H. (2020). Comparison of visual function and retinal structure between phases of multiple sclerosis. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. -
Characterization of Retinal vascular changes in Multiple Sclerosis using Adaptive Optics and OCTA
Khushzad, F., Yarp, J., Hargrave, A., Sredar, N., Mahesh, V., Tomczak, A., … Moss, H. (2020). Characterization of Retinal vascular changes in Multiple Sclerosis using Adaptive Optics and OCTA. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. -
In-depth B cell immunophenotyping to monitor response to anti-CD20 therapy in CNS autoimmunity.
Su, E., Wetzel, N. S., Oak, J., Kipp, L., & Han, M. H. (2020). In-depth B cell immunophenotyping to monitor response to anti-CD20 therapy in CNS autoimmunity. Multiple Sclerosis and Related Disorders, 46, 102594. -
Novel Foveal Features Associated With Vision Impairment in Multiple Sclerosis.
Hargrave, A., Sredar, N., Khushzad, F., Yarp, J., Tomczak, A., Han, M., … Moss, H. E. (2021). Novel Foveal Features Associated With Vision Impairment in Multiple Sclerosis. Investigative Ophthalmology & Visual Science, 62(12), 27. -
Feasibility and acceptability of virtually coaching residents on communication skills: a pilot study.
Sasnal, M., Miller-Kuhlmann, R., Merrell, S. B., Beres, S., Kipp, L., Lee, S., … Gold, C. A. (2021). Feasibility and acceptability of virtually coaching residents on communication skills: a pilot study. BMC Medical Education, 21(1), 513. -
Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM.
Lanz, T. V., Brewer, R. C., Ho, P. P., Moon, J.-S. S., Jude, K. M., Fernandez, D., … Robinson, W. H. (2022). Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM. Nature. -
Positive perception of pharmacogenetic testing for psychotropic medications
Lanktree, M. B., Zai, G., VanderBeek, L. E., Giuffra, D. E., Smithson, D. S., Kipp, L. B., … Kennedy, J. L. (2014). Positive perception of pharmacogenetic testing for psychotropic medications. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 29(3), 287–291. -
Human KIR + CD8 + T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19.
Li, J., Zaslavsky, M., Su, Y., Sikora, M. J., van Unen, V., Christophersen, A., … Davis, M. M. (2021). Human KIR + CD8 + T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19. BioRxiv : the Preprint Server for Biology. -
KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19.
Li, J., Zaslavsky, M., Su, Y., Guo, J., Sikora, M. J., van Unen, V., … Davis, M. M. (2022). KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science (New York, N.Y.), eabi9591. -
Primary central nervous system histiocytic sarcoma presenting as neuromyelitis optica
Nirschl, J., Rogawski, D., McDonald, J., Nie, E., Schwartz, N., Scott, B., … Vogel, H. (2022). Primary central nervous system histiocytic sarcoma presenting as neuromyelitis optica. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. OXFORD UNIV PRESS INC. -
A rare neuromyelitis optica mimic: Primary CNS histiocytic sarcoma.
Rogawski, D. S., Nirschl, J. J., McDonald, J., Nie, E., Schwartz, N. U., Vogel, H., … Kipp, L. B. (2022). A rare neuromyelitis optica mimic: Primary CNS histiocytic sarcoma. Multiple Sclerosis (Houndmills, Basingstoke, England), 28(10), 1651–1654. -
SARS-CoV-2 Vaccine Immune Response on Anti-Complement Therapy, Eculizumab
Sattarnezhad, N., Sumera, J., McDonald, J., Nie, E., Tomczak, A., Joseph, Y., … Han, M. (2023). SARS-CoV-2 Vaccine Immune Response on Anti-Complement Therapy, Eculizumab. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Longitudinal imaging of microscopic scattering features in the foveal avascular zone of multiple sclerosis using adaptive optics ophthalmoscopy
Hargrave, A., Navarro, S., Buickians, D., Kipp, L., Han, M., Kowalski, B., … Moss, H. (2023). Longitudinal imaging of microscopic scattering features in the foveal avascular zone of multiple sclerosis using adaptive optics ophthalmoscopy. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. -
Catalytic Antibodies May Contribute to Demyelination in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Jensen, M. A., Dafoe, M. L., Wilhelmy, J., Cervantes, L., Okumu, A. N., Kipp, L., … Davis, R. W. (2023). Catalytic Antibodies May Contribute to Demyelination in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Biochemistry. -
Epidemiological and Clinical Outcome Determinants of Post-COVID-19 Myelopathy
Sumera, J., Sarkar, T. T., McDonald, J., Sattarnezhad, N., Nie, E., Kipp, L., … Lock, C. (2023). Epidemiological and Clinical Outcome Determinants of Post-COVID-19 Myelopathy. MULTIPLE SCLEROSIS JOURNAL. SAGE PUBLICATIONS LTD. -
Evaluation of the quality and the productivity of neuroradiological reading of multiple sclerosis follow-up MRI scans using an intelligent automation software.
Federau, C., Hainc, N., Edjlali, M., Zhu, G., Mastilovic, M., Nierobisch, N., … Wintermark, M. (2024). Evaluation of the quality and the productivity of neuroradiological reading of multiple sclerosis follow-up MRI scans using an intelligent automation software. Neuroradiology. -
Clinical Features of Neurotoxicity Following CD19 CAR T-cell Therapy in Mantle Cell Lymphoma.
Nie, E. H., Su, Y.-J. J., Baird, J. H., Agarwal, N., Bharadwaj, S., Weng, W.-K. K., … Frank, M. J. (2024). Clinical Features of Neurotoxicity Following CD19 CAR T-cell Therapy in Mantle Cell Lymphoma. Blood Advances. -
Single-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort.
Phongpreecha, T., Mathi, K., Cholerton, B., Fox, E. J., Sigal, N., Espinosa, C., … Montine, T. J. (2024). Single-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort. Molecular Neurodegeneration, 19(1), 59. -
Longitudinal foveal adaptive optics scanning laser ophthalmoscopy in multiple sclerosis
Hargrave, A., Buickians, D., Navarro, S. E. V., Parthasarathi, P., Kipp, L., Han, M. H., … Moss, H. E. (2024). Longitudinal foveal adaptive optics scanning laser ophthalmoscopy in multiple sclerosis. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. -
In Vivo OCT Imaging of Muller and Macrophage-Like Cells in the Retinas of Patients with and without MS and related diseases
Elizabeth, S., Navarro, V., Han, M. H., Kipp, L., Hargrave, A., Parthasarathi, P., … Moss, H. E. (2024). In Vivo OCT Imaging of Muller and Macrophage-Like Cells in the Retinas of Patients with and without MS and related diseases. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. -
High-dimensional, targeted immunogenetic profiles of "idiopathic" myelitis with correlative risk and protective factors
Sarkar, T. T., Sumera, J., Tomczak, A., Bachar, S., Ton-Nu, C., Joseph, Y., … Lock, C. (2024). High-dimensional, targeted immunogenetic profiles of "idiopathic" myelitis with correlative risk and protective factors. MULTIPLE SCLEROSIS JOURNAL. SAGE PUBLICATIONS LTD. -
Paired serum and CSF immunoprofiling guides treatment of refractory CNS autoimmunity
Wu, D., Sarkar, T. T., Nie, E., Galetta, K., McDonald, J., Tomczak, A., … Han, M. (2024). Paired serum and CSF immunoprofiling guides treatment of refractory CNS autoimmunity. MULTIPLE SCLEROSIS JOURNAL. SAGE PUBLICATIONS LTD. -
Longitudinal study of foveal scattering features in multiple sclerosis using adaptive optics scanning light ophthalmoscopy
Hargrave, A., Buickians, D., Ayubi, G., Parthasarathi, P., Navarro, S. E. V., Kowalski, B., … Moss, H. (2025). Longitudinal study of foveal scattering features in multiple sclerosis using adaptive optics scanning light ophthalmoscopy. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. -
Major depressive disorder in multiple sclerosis associated with differences in disease modifying therapy and demographics.
Lee, N. J., Hui, G., Pike, C. W., Galetta, K., Kipp, L. B., Dunn, J., … Folmsbee, S. S. (2025). Major depressive disorder in multiple sclerosis associated with differences in disease modifying therapy and demographics. Frontiers in Neurology, 16, 1663778. -
Distinct Reactivity Patterns to EBV Nuclear Proteins and CNS Antigens Distinguish CNS Demyelinating Disorders from Systemic Autoimmunity
Sattarnezhad, N., Held, F., Babaei, M., Gawde, S., Ho, P., Barrett, A., … Robinson, W. (2025). Distinct Reactivity Patterns to EBV Nuclear Proteins and CNS Antigens Distinguish CNS Demyelinating Disorders from Systemic Autoimmunity. MULTIPLE SCLEROSIS JOURNAL. SAGE PUBLICATIONS LTD. -
EBV reprograms autoreactive anti-CNS B cells as antigen presenting cells in multiple sclerosis.
Younis, S., Rasouli, S., Loeffler, J. W., Sattarnezhad, N., Courtney, Y., Moutusy, S. I., … Robinson, W. H. (2026). EBV reprograms autoreactive anti-CNS B cells as antigen presenting cells in multiple sclerosis. BioRxiv : the Preprint Server for Biology.
-
Immunomodulatory receptors are differentially expressed in B and T cell subsets relevant to autoimmune disease.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
- Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Practice Locations
Multiple Sclerosis Center in Palo Alto Palo Alto, CA
Palo Alto, CAMultiple Sclerosis Center in Palo Alto
213 Quarry Rd
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereMultiple Sclerosis Center Palo Alto, CA
Palo Alto, CAMultiple Sclerosis Center
213 Quarry Rd
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Review Summary
Dr. Kipp is known for a friendly and patient approach. Individuals find him easy to talk to and describe him as knowledgeable and thorough. He listens carefully, answers questions, and offers helpful advice.
The summary was created by AI, based on recent patient reviews. Learn more
Was this result useful to you?
Patient Reviews
(139 reviews)
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records